Important note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.
Mononuclear phagocytes in the newborn: their relation to the state of relative immunodeficiency.
Am J Pediatr Hematol Oncol. 1983 Summer;5(2):189-98. Unique Identifier : AIDSLINE MED/83306424 Mills EL
Abstract:
The neonatal period is a state of relative immunodeficiency during which newborns are particularly vulnerable to bacterial, protozoal, and viral infections. In addition, they localize infection poorly, mount a sluggish antibody response to injected antigens and are relatively anergic. Both in vivo and in vitro studies suggest that functional immaturity of neonatal macrophages may contribute to this immunologic hyporesponsiveness. Resistance to viral and bacterial infection and production of antibody can be enhanced in neonates by injection of adult macrophages. Specific functional defeats in newborns' monocytes have been demonstrated in their capacity to chemotax, to resist intracellular multiplication of virus and to effect antibody-dependent cell-mediated cytotoxicity towards virus-infected target cells. Monocytes from newborns also appear to present antigen poorly, and to co-operate with T-lymphocytes in the suppression of IgG-production by B cells.
Keywords: Antibody Formation Antibody-Dependent Cell Cytotoxicity Blood Bactericidal Activity Chemotaxis Herpes Simplex/IMMUNOLOGY Human Immune Adherence Reaction *Immunocompetence *Infant, Newborn Infant, Newborn, Diseases/IMMUNOLOGY Listeria Infections/IMMUNOLOGY Macrophages/*IMMUNOLOGY Monocytes/*IMMUNOLOGY Oxygen Consumption Phagocytosis JOURNAL ARTICLE REVIEW
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.